PLUS THERAPEUTICS, INC. — Major Shareholding Notification 2018

Jan 4, 2018

SC 13G/A 1 a18-2147_1sc13ga.htm SC 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934 (Amendment No. 1)

Cytori Therapeutics, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

23283K204

(CUSIP Number)

December 31, 2017

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o	Rule 13d-1(b)
x	Rule 13d-1(c)
o	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would aler disclsoures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SEQ.=1,FOLIO='',FILE='C:\jms\110008\18-2147-1\task8684757\2147-1-ba.htm',USER='110008',CD='Jan 4 21:50 2018'

Item 1.	(a)	Name of Issuer Cytori Therapeutics, Inc.
	(b)	Address of Issuer’s Principal Executive Offices 3020 Callan Road San Diego, CA 92121
Item 2.
	(a)	Name of Person Filing Azaya Therapeutics, Inc.
	(b)	Address of Principal Business Office or, if none, Residence 250 W. Nottingham, Suite 120 San Antonio, TX 78209
	(c)	Citizenship Unites States
	(d)	Title of Class of Securities Common Stock
	(e)	CUSIP Number 23283K204
Item 3.	If this statement is filed pursuant to Secs. 240.13d-1(b) or (c), check whether the person filing is a:
	(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
	(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
	(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
	(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	o	An investment adviser in accordance with Sec. 240.13d-1(b)(1)(ii)(E);
	(f)	o	An employee benefit plan or endowment fund in accordance with Sec. 240.13d-1(b)(1)(ii)(F);
	(g)	o	A parent holding company or control person in accordance with Sec. 240.13d-1(b)(1)(ii)(G);
	(h)	o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	o	Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).

2

SEQ.=1,FOLIO='2',FILE='C:\jms\110008\18-2147-1\task8684757\2147-1-bc.htm',USER='110008',CD='Jan 4 21:51 2018'

Item 4.	Ownership. — (a)	Amount beneficially owned 293,310
	(b)	Percent of class 1.2
	(c)	Number of shares as to which such person has:
		(i)	Sole power to vote or to direct the vote 293,310
		(ii)	Shared power to vote or to direct the vote none
		(iii)	Sole power to dispose or to direct the disposition 293,310
		(iv)	Shred power to dispose or to direct the disposition of none
Item 5.	Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x .
Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being reported on By the Parent Holding Company.
Not applicable
Item 8.	Identification and Classification of Members of the Group.
Not applicable
Item 9.	Notice of Dissolution of the Group.
Not applicable

3

SEQ.=1,FOLIO='3',FILE='C:\jms\110008\18-2147-1\task8684757\2147-1-bc.htm',USER='110008',CD='Jan 4 21:51 2018'

Item 10.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 4, 2018
By:	/s/ John C. Kerr
Name: John C. Kerr
Title: President

4

SEQ.=1,FOLIO='4',FILE='C:\jms\110008\18-2147-1\task8684757\2147-1-bc.htm',USER='110008',CD='Jan 4 21:51 2018'